[Federal Register Volume 63, Number 93 (Thursday, May 14, 1998)]
[Notices]
[Page 26816]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-12776]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP)
meetings:
Name of SEP: Endothelial Dysfunction in HIV Infection.
Date: June 9-10, 1998.
Time: 7:00 p.m.
Place: Holiday Inn Gaithersburg, 2 Montgomery Village Avenue,
Gaithersburg, Maryland 20879.
Contact Person: Ramesh Vemuri, Ph.D., Two Rockledge Center, Room
7194, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301)
435-0476.
Purpose/Agenda: To review and evaluate grant applications.
Name of SEP: Molecular and Physical Characterization of the
Vulnerable Plaque.
Date: June 17-18, 1998.
Time: 7:00 p.m.
Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda,
Maryland 20814.
Contact Person: Ivan Baines, Ph.D., Two Rockledge Center, Room
7184, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301)
435-0277.
Purpose/Agenda: To review and evaluate grant applications.
These meetings will be closed in accordance with the provisions
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.
Applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart
and Vascular Diseases Research; 93.838, Lung Diseases Research; and
93.839, Blood Diseases and Resources Research, National Institutes
of Health)
Dated: May 7, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-12776 Filed 5-13-98; 8:45 am]
BILLING CODE 4140-01-M
